Addressing cannabis consumption among patients with hyperemesis gravidarum.

Shelley L Galvin, Carol C Coulson
Author Information
  1. Shelley L Galvin: Department of Obstetrics and Gynecology, Mountain Area Health Education Center, Asheville, NC.
  2. Carol C Coulson: Department of Obstetrics and Gynecology, Mountain Area Health Education Center, Asheville, NC.

Abstract

Severe nausea and vomiting of pregnancy and hyperemesis gravidarum affect up to 3% of all pregnant people, causing substantial maternal and neonatal morbidity, suffering, and financial cost. Evidence supports the association of cannabis consumption with symptoms of severe nausea and vomiting of pregnancy or hyperemesis gravidarum as the general public has come to believe that cannabis is a natural, safe antiemetic. Cannabis consumption in pregnancy is discouraged strongly by the Surgeon General of the United States and the American College of Obstetricians and Gynecologists because of evidence of potential harms. Symptoms of intractable, severe nausea and vomiting of pregnancy or hyperemesis gravidarum associated with cannabis consumption may be unrecognized cannabinoid hyperemesis syndrome, and this syndrome may be more common than previously thought. Cannabis consumption is especially detrimental when causing or exacerbating debilitating symptoms such as the intense, persistent, recurrent, or cyclic vomiting and associated dehydration and other sequelae of cannabinoid hyperemesis syndrome. Open discussion of cannabis consumption during pregnancy is very challenging for patients and maternity care providers in our current environment of variable legal status across states and variable degrees of personal and societal acceptance. Evidence-based medical knowledge, guidance, tools, and skills are needed to differentially diagnose and treat cannabinoid hyperemesis syndrome in pregnancy. Researchers, clinicians, and medical specialty organizations must work together to strengthen the evidence base and develop or refine the necessary guidelines and tools for maternity care provider skill development, and to increase public and patient awareness of cannabinoid hyperemesis syndrome, specifically during pregnancy.

Keywords

References

  1. BMJ. 2019 Jul 19;366:l4336 [PMID: 31324702]
  2. Ann Pharmacother. 2019 Nov;53(11):1145-1152 [PMID: 31104487]
  3. Cannabis Cannabinoid Res. 2018 Mar 01;3(1):74-84 [PMID: 29662957]
  4. Am J Obstet Gynecol. 2022 Nov;227(5):793-794 [PMID: 35839917]
  5. Obstet Gynecol. 2016 Apr;127(4):681-687 [PMID: 26959210]
  6. BJOG. 2020 Jul;127(8):983-992 [PMID: 32056342]
  7. BMC Pregnancy Childbirth. 2017 Feb 28;17(1):75 [PMID: 28241811]
  8. Pain Med. 2020 Nov 1;21(11):3180-3186 [PMID: 31909803]
  9. Am J Health Promot. 2020 May;34(4):436-439 [PMID: 31916839]
  10. JAMA Netw Open. 2021 Feb 1;4(2):e210148 [PMID: 33630081]
  11. Obstet Gynecol. 2017 Oct;130(4):e205-e209 [PMID: 28937574]
  12. Geburtshilfe Frauenheilkd. 2022 May 06;82(5):517-527 [PMID: 35528189]
  13. Cannabis Cannabinoid Res. 2020 Jun 05;5(2):172-182 [PMID: 32656349]
  14. Complement Ther Med. 2021 May;58:102675 [PMID: 33539943]
  15. Drug Alcohol Depend. 2019 Mar 1;196:14-20 [PMID: 30658220]
  16. Obstet Gynecol. 2015 Jun;125(6):1484-1486 [PMID: 25774930]
  17. J Addict Med. 2017 May/Jun;11(3):211-216 [PMID: 28252456]
  18. Eur J Intern Med. 2018 Mar;49:12-19 [PMID: 29307505]
  19. Health Technol Assess. 2016 Oct;20(74):1-268 [PMID: 27731292]
  20. Am J Emerg Med. 2022 Jun;56:342-343 [PMID: 34607735]
  21. Can Fam Physician. 2020 Feb;66(2):98-103 [PMID: 32060189]
  22. Hawaii J Med Public Health. 2014 Sep;73(9):283-7 [PMID: 25285255]
  23. West J Emerg Med. 2018 Mar;19(2):380-386 [PMID: 29560069]
  24. P T. 2017 Mar;42(3):180-188 [PMID: 28250701]
  25. J Clin Gastroenterol. 2022 Apr 1;56(4):331-338 [PMID: 35258504]
  26. Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:178-187 [PMID: 31126753]
  27. Addiction. 2022 Jun;117(6):1510-1517 [PMID: 34590359]
  28. J Pharm Pract. 2021 Oct;34(5):786-793 [PMID: 32613883]
  29. Med Cannabis Cannabinoids. 2018 Nov 15;1(2):73-95 [PMID: 34676325]
  30. Subst Abus. 2018 Jan 2;39(1):9-13 [PMID: 28723278]
  31. Ann Gastroenterol. 2020 Nov-Dec;33(6):571-578 [PMID: 33162734]
  32. Curr Drug Abuse Rev. 2011 Dec;4(4):241-9 [PMID: 22150623]
  33. Neurogastroenterol Motil. 2019 Jun;31 Suppl 2:e13606 [PMID: 31241817]
  34. Case Rep Obstet Gynecol. 2018 Sep 16;2018:9746062 [PMID: 30305971]
  35. JAMA Intern Med. 2018 Oct 1;178(10):1423-1424 [PMID: 30128499]
  36. Gut. 2004 Nov;53(11):1566-70 [PMID: 15479672]
  37. BMC Fam Pract. 2019 Jan 22;20(1):17 [PMID: 30669979]
  38. J Reprod Med. 2015 Sep-Oct;60(9-10):430-2 [PMID: 26592070]
  39. Int J Emerg Med. 2020 Oct 28;13(1):52 [PMID: 33115404]
  40. Cannabis Cannabinoid Res. 2018 Mar 01;3(1):66-73 [PMID: 29588917]
  41. J Popul Ther Clin Pharmacol. 2013;20(2):e149-60 [PMID: 23913638]
  42. Arch Gynecol Obstet. 2022 Nov;306(5):1519-1529 [PMID: 35226159]
  43. J Stud Alcohol Drugs. 2020 Nov;81(6):824-825 [PMID: 33308413]
  44. Cannabis Cannabinoid Res. 2022 Feb;7(1):11-15 [PMID: 33998873]
  45. JAMA. 2021 Nov 2;326(17):1745-1747 [PMID: 34570168]
  46. Obstet Gynecol. 2019 Jan;133(1):98-104 [PMID: 30531577]
  47. BMJ. 2019 Sep 23;366:l5587 [PMID: 31548251]
  48. J Matern Fetal Neonatal Med. 2020 Apr;33(8):1405-1411 [PMID: 30173590]
  49. Obstet Gynecol. 2002 Jul;100(1):94-100 [PMID: 12100809]
  50. JAMA. 2019 Jul 9;322(2):167-169 [PMID: 31211824]
  51. Am J Emerg Med. 2021 May;43:35-40 [PMID: 33493995]
  52. Pharmacology. 2017;100(3-4):161-171 [PMID: 28641304]
  53. Cannabis Cannabinoid Res. 2020 Jun 05;5(2):132-144 [PMID: 32656345]
  54. Am J Obstet Gynecol. 2021 Jun;224(6):629-631 [PMID: 33713683]
  55. Patient Educ Couns. 2016 Sep;99(9):1446-51 [PMID: 27316326]
  56. J Womens Health (Larchmt). 2020 Jul;29(7):919-926 [PMID: 32011205]
  57. J Fam Pract. 2014 May;63(5):257-9 [PMID: 24795910]
  58. BJOG. 2011 Oct;118(11):1302-13 [PMID: 21749625]
  59. Isr J Health Policy Res. 2016 Oct 10;5:43 [PMID: 27766142]
  60. Addiction. 2022 Jun;117(6):1520-1521 [PMID: 34888981]
  61. J Cannabis Res. 2020 Jan 30;2(1):4 [PMID: 33526133]
  62. Obstet Gynecol. 2020 Apr;135(4):e178-e188 [PMID: 32217980]
  63. J Palliat Med. 2019 Oct;22(10):1208-1212 [PMID: 31094609]
  64. J Midwifery Womens Health. 2021 Jan;66(1):96-100 [PMID: 33534190]
  65. Cannabis Cannabinoid Res. 2022 Aug;7(4):508-515 [PMID: 33998899]
  66. Chem Biodivers. 2007 Aug;4(8):1614-48 [PMID: 17712811]
  67. Hum Reprod. 2016 Aug;31(8):1675-84 [PMID: 27251205]
  68. Complement Ther Clin Pract. 2006 Feb;12(1):27-33 [PMID: 16401527]
  69. Emerg Med Pract. 2018 Aug;20(8):1-20 [PMID: 30020736]
  70. J Addict Med. 2020 Dec;14(6):467-474 [PMID: 32011411]
  71. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:162-167 [PMID: 31923736]
  72. Am J Hosp Palliat Care. 2017 Feb;34(1):85-91 [PMID: 26377551]
  73. BMC Nurs. 2019 Dec 09;18:66 [PMID: 31827392]
  74. Cannabis Cannabinoid Res. 2018 Oct 01;3(1):195-202 [PMID: 30426072]
  75. Psychopharmacology (Berl). 2022 May;239(5):1509-1519 [PMID: 35020045]
  76. Arch Gynecol Obstet. 2011 Nov;284(5):1095-7 [PMID: 21170540]
  77. CJEM. 2019 Jul;21(4):477-481 [PMID: 30806339]
  78. Womens Health Issues. 2016 Jul-Aug;26(4):452-9 [PMID: 27131908]
  79. Obstet Gynecol Surv. 2020 Jan;75(1):50-60 [PMID: 31999353]
  80. Obstet Gynecol. 2018 Jan;131(1):e15-e30 [PMID: 29266076]
  81. Obstet Gynecol. 2019 May;133(5):952-961 [PMID: 30969217]

Word Cloud

Created with Highcharts 10.0.0pregnancyhyperemesiscannabisvomitingconsumptionsyndromenauseagravidarumcannabinoidseverecausingsymptomspublicCannabisevidenceassociatedmaypatientsmaternitycarevariablemedicaltoolsSevereaffect3%pregnantpeoplesubstantialmaternalneonatalmorbiditysufferingfinancialcostEvidencesupportsassociationgeneralcomebelievenaturalsafeantiemeticdiscouragedstronglySurgeonGeneralUnitedStatesAmericanCollegeObstetriciansGynecologistspotentialharmsSymptomsintractableunrecognizedcommonpreviouslythoughtespeciallydetrimentalexacerbatingdebilitatingintensepersistentrecurrentcyclicdehydrationsequelaeOpendiscussionchallengingproviderscurrentenvironmentlegalstatusacrossstatesdegreespersonalsocietalacceptanceEvidence-basedknowledgeguidanceskillsneededdifferentiallydiagnosetreatResearcherscliniciansspecialtyorganizationsmustworktogetherstrengthenbasedeveloprefinenecessaryguidelinesproviderskilldevelopmentincreasepatientawarenessspecificallyAddressingamongusedisorderdifferentialdiagnosis

Similar Articles

Cited By